Torrent Pharmaceuticals Limited share price
NSE: TORNTPHARM · ISIN INE685A01028
Key numbers
- Market cap
- ₹ 1,89,747 Cr
- Current price
- ₹ 4,988.50
- 52-week high / low
- ₹ 5,250 / 3,481
- Stock P/E
- 79.7
- Book value
- ₹ 247.9
- Dividend yield
- 0.76%
- ROCE
- 19.0%
- ROE
- 27.1%
- Debt to equity
- 1.79
- Sales growth (3 yrs)
- 13.3%
- Profit growth (3 yrs)
- 20.2%
- 1-year return
- 38.0%
About Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, ProZuca, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 3,128 | 3,246 | 3,251 | 4,128 | 4,835 |
| Operating profit | 1,032 | 1,083 | 1,088 | 1,356 | 1,664 |
| Net profit | 548 | 591 | 635 | 389 | 566 |
| EPS (₹) | 16.19 | 17.45 | 18.77 | 11.51 | 14.87 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.